Back

Eicosapentaenoic acid therapy is associated with decreased coronary plaque instability assessed using optical frequency domain imaging

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Lipid management and outcome Lipid-Lowering Agents ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Takao Konishi

Hokkaido University, Sapporo (Japan)

6 More presentations in this session

Presentation thumbnail
Professor A. Her (Chuncheon, KR)
Abstract
Presentation thumbnail
Assistant Professor J. Dopheide (Thun, CH)
Abstract Slides
Presentation thumbnail
Doctor C. Ballantyne (Houston, US)
Abstract Slides
Presentation thumbnail
Doctor E. Fountas (Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor P. Guedeney (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Lipid management and outcome

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The clinical impact of polyunsaturated fatty acid on clinical outcomes in acute coronary syndrome with dyslipidemia: HIJ-PROPER sub-analysis
31 August 2019
thumbnail
Congress Presentation
Diagnosis of coronary plaque rupture, plaque erosion, and calcified nodule by using near-infrared spectroscopy intravascular ultrasound
31 August 2019
thumbnail
Congress Presentation
Eicosapentaenoic acid (EPA) modulates inflammasome activation in monocyte-derived macrophages isolated from individuals with and without established atherosclerotic cardiovascular disease (ASCVD).
31 August 2025
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources